Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Total Current Liabilities (2024 - 2025)

Carlsmed (CARL) has disclosed Total Current Liabilities for 2 consecutive years, with $14.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 61.94% year-over-year to $14.3 million, compared with a TTM value of $14.3 million through Dec 2025, up 61.94%, and an annual FY2025 reading of $14.3 million, up 61.94% over the prior year.
  • Total Current Liabilities was $14.3 million for Q4 2025 at Carlsmed, up from $10.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $14.3 million in Q4 2025 and bottomed at $8.8 million in Q4 2024.